Yes. Ozempic is semaglutide. Semaglutide is the active molecule, and Ozempic is one of the Novo Nordisk brand names that carries it, alongside Wegovy and Rybelsus. Compounded semaglutide at Telos Rx is a separate, non-approved category.
The confusion is fair: one molecule, several trademarks, several approved uses, and a compounded version that is none of the above. This page maps every name to the label it actually belongs to.
Semaglutide Is the Molecule. Ozempic Is a Brand Name.
Every prescription drug has two identities. One is the active ingredient, which is chemistry. The other is the brand name, which is a trademark owned by a company.
Semaglutide is the ingredient: a GLP-1 receptor agonist that mimics a gut hormone released after eating. Ozempic is a Novo Nordisk trademark for one approved product built on that ingredient. Asking what is Ozempic made of has the same shape as asking what is in Tylenol.
So "ozempic semaglutide" and "semaglutide ozempic" are not two things being compared. They are an ingredient and a label for it. The full biology is in What Is Semaglutide? The Complete Guide.
The Name-to-Label Map
Three Novo Nordisk brands carry semaglutide in the United States. They are not interchangeable, because each one was studied and approved for a different job. Here is what the current FDA labels say.
| Name | Form | FDA-approved use, per the label |
|---|---|---|
| Ozempic | Once-weekly subcutaneous injection; once-daily tablets, 1.5 mg, 4 mg and 9 mg, are also approved | Glycemic control in adults with type 2 diabetes; reducing major adverse cardiovascular events in type 2 diabetes with established cardiovascular disease; reducing kidney outcome risk in type 2 diabetes with chronic kidney disease (injection only) |
| Wegovy | Once-weekly subcutaneous injection; once-daily tablets, 1.5 mg, 4 mg, 9 mg and 25 mg, are also approved | Reducing excess body weight in adults and in patients aged 12 and older; reducing major adverse cardiovascular events in adults with established cardiovascular disease and obesity or overweight; noncirrhotic MASH with moderate to advanced liver fibrosis |
| Rybelsus | Once-daily tablet, 3 mg, 7 mg and 14 mg | Glycemic control in adults with type 2 diabetes; reducing major adverse cardiovascular events in adults with type 2 diabetes at high risk |
| Compounded semaglutide | Varies by prescription | None. Compounded semaglutide is not FDA-approved and carries no FDA-approved indication |
You can read the source documents yourself. The Ozempic label, Wegovy label and oral semaglutide label are all on DailyMed.
One detail has changed recently: the oral side of the family has expanded. Current labeling now covers oral semaglutide tablets under the Ozempic name as well as Rybelsus, and the Wegovy label covers a tablet alongside the injection. More in The Semaglutide Pill: Rybelsus, the Wegovy Pill & Compounded.
Ozempic vs Wegovy: One Molecule, Two Jobs
This is the question behind most searches. The honest answer is that the chemistry is identical and the paperwork is not.
Ozempic and Wegovy both contain semaglutide, both are made by Novo Nordisk, and both are sold as weekly injections, with each brand name now also covering an oral tablet. What separates them is which trial program each brand ran and therefore which population and outcome the FDA approved. Ozempic was built around type 2 diabetes. Wegovy was built around weight management, at higher maintenance dosing.
Wegovy's cardiovascular indication came later, from a trial of 17,604 randomized participants with established cardiovascular disease and obesity or overweight but not diabetes. Those are findings in a specific enrolled population, not a promise about any individual. Wider evidence is in GLP-1 cardiovascular benefits research, and the liver angle in GLP-1 for fatty liver disease.
So wegovy vs ozempic is a labelling comparison, not a chemistry one. Tirzepatide runs the same pattern with two brands of its own, explained in Is Mounjaro Tirzepatide? and compared head to head in Mounjaro vs Ozempic.
The Dose Ladder Behind the Brand Difference
Part of what distinguishes the two injections is where the label lets the dose go. The Wegovy label describes a stepped escalation rather than starting at a target dose:
- 0.25 mg once weekly for weeks 1 to 4
- 0.5 mg once weekly for weeks 5 to 8
- 1 mg once weekly for weeks 9 to 12
- 1.7 mg once weekly for weeks 13 to 16
- 2.4 mg once weekly as the recommended maintenance dose
- 7.2 mg once weekly, which the label allows as a higher option for weight reduction in adults
That ladder exists to let the gut adapt, which is why side effects cluster during titration. These are label figures, not instructions, and your prescribing provider decides the actual schedule. More detail sits in Semaglutide Dosage: The Titration Schedule Explained.
If the naming is now clear and the real question is whether semaglutide suits your health history, the next step is a written intake reviewed by a licensed provider.
See semaglutide at Telos RxWhere Compounded Semaglutide Fits
Compounded semaglutide is a fourth category, and it is the one most often described inaccurately.
Compounded semaglutide is not FDA-approved. It is prepared by licensed US compounding pharmacies against a prescription written for an individual patient, and it does not go through the agency review that Ozempic, Wegovy and Rybelsus went through. It is also not a generic, because no FDA-approved generic semaglutide exists. That distinction is unpacked in Is Ozempic a Semaglutide? Brand vs. Generic Explained.
Compounded preparations share the active molecule with the brands. What they do not share is an approved indication, a fixed presentation, or a guaranteed concentration match to any brand pen. Availability can differ by state. The practical version is in Compounded Semaglutide via Telehealth.
Sorting Out the Pill Question
Oral semaglutide is real and approved, which surprises people who assume every GLP-1 is an injection. Rybelsus is a tablet for type 2 diabetes at 3 mg, 7 mg and 14 mg once daily, taken on an empty stomach with a small sip of water. It is no longer the only one: Ozempic tablets sit on that same label at 1.5 mg, 4 mg and 9 mg, and Wegovy tablets carry their own weight-management and cardiovascular indications.
What oral semaglutide is not is orforglipron, sold as Foundayo. That is also an oral GLP-1 pill, but it is a completely different molecule from Eli Lilly, and it is neither semaglutide nor tirzepatide. Two pills, two molecules, one muddled results page. The routes are compared in oral vs injectable semaglutide, and the tirzepatide side in Tirzepatide Pills & Oral Tirzepatide.
Safety Language That Applies to Every Semaglutide Product
The brand name changes. The warnings do not.
Semaglutide products carry a boxed warning: in rodents, semaglutide caused thyroid C-cell tumors at clinically relevant exposures, and whether that translates to humans is not established. The labels contraindicate use in anyone with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.
The most commonly reported adverse effects are gastrointestinal: nausea, vomiting, diarrhea and constipation, usually worst while the dose is climbing. Less common but serious risks include pancreatitis and gallbladder disease. Semaglutide is not for use in pregnancy. More is in semaglutide side effects, answered.
How Telos Rx Handles Semaglutide
Telos Rx is a LegitScript-certified, online-first telehealth service offering compounded GLP-1 options rather than branded ones, dispensed through licensed US compounding pharmacy partners. There is no appointment to book: you complete a written intake, and a licensed provider reviews it asynchronously, often within hours.
As of publication, compounded semaglutide is listed as low as $99 per month, with flat pricing that does not rise as a provider titrates your dose. Shipping is free with 48-hour delivery if you are approved, plans are FSA and HSA eligible, and you can cancel anytime. How that compares with brand pricing is broken down in Semaglutide Cost: Compounded vs Ozempic & Wegovy.
Still weighing molecules rather than brands? Compare them on tirzepatide vs semaglutide or read the compounded comparison. Every prescription is subject to medical approval by a licensed provider, and approval is not guaranteed.
Ozempic, Wegovy and Rybelsus are registered trademarks of Novo Nordisk A/S. Telos Rx is not affiliated with or endorsed by Novo Nordisk and does not sell those products.
Frequently Asked Questions
Is Ozempic semaglutide?
Yes. Semaglutide is the active ingredient and Ozempic is a Novo Nordisk brand name for one FDA-approved product containing it. The brand name identifies the specific product, its strengths and its approved use. The ingredient name identifies the molecule itself, which is shared with Wegovy and Rybelsus.
Is Wegovy semaglutide as well?
Yes. Wegovy contains the same active molecule as Ozempic and comes from the same manufacturer. It is approved for reducing excess body weight, for reducing major adverse cardiovascular events in adults with established cardiovascular disease and obesity or overweight, and for noncirrhotic MASH with moderate to advanced liver fibrosis.
What is the difference between Ozempic and Wegovy?
Chemically, nothing: both are semaglutide, sold as once-weekly injections and, more recently, as oral tablets. The difference is regulatory. Ozempic is approved around type 2 diabetes and its cardiovascular and kidney outcomes, while Wegovy is approved for weight management at higher maintenance dosing plus its own cardiovascular and liver indications. They are not interchangeable.
Is Rybelsus the same medicine as Ozempic?
Same molecule, different route. Rybelsus is oral semaglutide taken as a daily tablet at 3 mg, 7 mg or 14 mg, approved for glycemic control in adults with type 2 diabetes and for reducing major adverse cardiovascular events in high-risk type 2 diabetes. Ozempic is the weekly injection, though Ozempic tablets at 1.5 mg, 4 mg and 9 mg now share that same oral label.
Is compounded semaglutide FDA-approved?
No. Compounded semaglutide is not FDA-approved and has no FDA-approved indication. It is prepared by licensed US compounding pharmacies for an individual patient under a valid prescription, and it has not been through the FDA review that branded products completed. It is also not a generic version of any approved product.
Does Telos Rx prescribe Ozempic, Wegovy or Rybelsus?
No. Telos Rx offers compounded GLP-1 options, including compounded semaglutide and compounded tirzepatide, in weekly injection, oral and sublingual formats. Those branded products belong to Novo Nordisk and are named here for explanation only. Any prescription is subject to medical approval by a licensed provider.
TelosRX is LegitScript-certified. Compounded medications are not FDA-approved and are prepared under federal compounding regulations. Approval is subject to evaluation by a licensed provider; approval is not guaranteed. Individual results vary. TelosRX operates as an online-first, asynchronous telehealth service.
Now that the names line up, the useful next step is finding out whether the molecule fits you. Start on the compounded semaglutide page, then complete the written intake at start your online visit. A licensed provider reviews every request, and approval is not guaranteed.